Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Friday, May 3, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Authors
Posts by admin
admin
1860 POSTS
6 COMMENTS
Latest Pharma-News
Bristol-Myers Squibb Company announced U.S. FDA accepted its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) plus Yervoy (ipilimumab) for first-line...
admin
-
January 16, 2020
0
Latest Pharma-News
Imago Receives Fast Track Designation from U.S. FDA for Bomedemstat for the Treatment of Essential Thrombocythemia
admin
-
January 16, 2020
0
Latest Pharma-News
MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab development for the treatment of the B cell malignancies
admin
-
January 16, 2020
0
Latest Pharma-News
CytoDyn Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab as an adjuvant therapy for the Treatment of Metastatic Triple-Negative...
admin
-
January 16, 2020
0
Latest Pharma-News
Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) for the treatment of Tumor-Induced Osteomalacia (TIO)
admin
-
January 16, 2020
0
Latest Pharma-News
BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference
admin
-
January 13, 2020
0
Latest Pharma-News
FDA grants breakthrough device designation to Reflow Medical’s temporary spur stent system for the treatment of below-the-knee (BTK) peripheral artery disease
admin
-
January 13, 2020
0
Latest Pharma-News
Novartis ligelizumab (QGE031) more effective than Xolair®(omalizumab) at inhibiting immunoglobulin E pathway responsible for chronic spontaneous urticaria
admin
-
January 13, 2020
0
Latest Pharma-News
Bayer and Evotec form a new strategic alliance focusing on the treatment of polycystic ovary syndrome
admin
-
January 13, 2020
0
Regulatory Affairs
Approval pathways of Fixed dose combination (FDC) in India
admin
-
January 12, 2020
0
Clinical Data Management
When to Start and Stop collecting Adverse Events
admin
-
January 11, 2020
0
Latest Pharma-News
Almirall signs a deliberate agreement with 23andMe to license rights of a bispecific monoclonal antibody designed to blocks all three isoforms of IL-36 cytokine
admin
-
January 10, 2020
0
1
...
142
143
144
...
155
Page 143 of 155
TOP AUTHORS
admin
1860 POSTS
6 COMMENTS
greeceman
1 POSTS
0 COMMENTS
wp-needuser
0 POSTS
0 COMMENTS
http://wordpresss.com
wpcron3e85df1d
0 POSTS
0 COMMENTS
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024